Safety, Tolerability and Efficacy of 28-day Inhaled CHF 6001 DPI in COPD Patients
Clinical trial NCT01730404 · COMPLETED
Trial details
- NCT number
- NCT01730404
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2013-10-01
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.